C3G is an ultra-rare, progressive kidney disease that initially presents mostly in children and young adults. 3,4,9 Each year, approximately 1-2 people per million worldwide are newly diagnosed with ...
New APPEAR-C3G data show Fabhalta sustained proteinuria reduction at 12 months1Upon Fabhalta initiation, improvement observed in estimated glomerular filtration rate (eGFR) slope - a key measure of ki ...